Falta de adherencia a ticagrelor frente a clopidogrel y riesgo de eventos en pacientes con SCA. Resultados del registro CREA-ARIAM-Reference-Cited by-同舟云学术

Falta de adherencia a ticagrelor frente a clopidogrel y riesgo de eventos en pacientes con SCA. Resultados del registro CREA-ARIAM

Published:2024-02 Issue:2 Volume:77 Page:113-124
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

Almendro-Delia Manuel,Padilla-Rodríguez Gloria,Hernández-Meneses Begoña,Blanco-Ponce Emilia,Arboleda-Sánchez José A.,Rodríguez-Yáñez Juan Carlos,Soto-Blanco José Manuel,Fernández-García Isabel,Castillo-Caballero José Manuel,García-Rubira Juan C.,Hidalgo-Urbano Rafael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease;Valgimigli;Eur J Cardiothorac Surg.,2018

2. The risk of cardiovascular events after an acute coronary event remains high, especially during the first year, despite revascularization;Abu-Assi;Rev Esp Cardiol.,2016

3. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome;Ho;JAMA.,2008

4. Premature ticagrelor discontinuation in secondary prevention of atherosclerotic CVD;Arora;J Am Coll Cardiol.,2019

5. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS):2 year results from a prospective observational study;Mehran;Lancet.,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing of P2Y12 Inhibitor Administration in Patients With STEMI Undergoing Primary PCI;Journal of the American College of Cardiology;2024-06